Plain-English translation of NCT06075524 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying how to get the most benefit from anti-PD-1 immunotherapy, a type of cancer treatment that helps your immune system fight cancer. By collecting and analyzing blood samples from patients during treatment, the study aims to identify markers—like specific molecules in your immune cells—that predict whether the medication is working well and to understand why some patients respond better than others.
While this medication works well for many people with advanced cancer, not all patients benefit equally, and doctors currently have limited ways to know early on whether the treatment will help. This study hopes to discover blood-based signals that could help doctors predict treatment success and potentially improve outcomes.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic periodically to have blood drawn—and optionally, a stool sample collected—while you receive your regular cancer treatment. The study team will also review your medical records and may use tissue samples from any previous biopsies you've had. There are no extra medications or procedures beyond what you'd normally have; the study is simply monitoring your immune response through these samples.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
United States